Aequus Pharmaceuticals (CVE:AQS) Shares Cross Below Fifty Day Moving Average – What’s Next?

Aequus Pharmaceuticals Inc. (CVE:AQS – Get Free Report)’s stock price crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of C$0.01 and traded as low as C$0.01. Aequus Pharmaceuticals shares last traded at C$0.01, with a volume of 100,000 shares changing hands.

Aequus Pharmaceuticals Price Performance

The company has a debt-to-equity ratio of 138.88, a quick ratio of 0.46 and a current ratio of 0.07. The company’s 50 day moving average price is C$0.01 and its 200-day moving average price is C$0.01. The company has a market cap of C$663,150.00, a price-to-earnings ratio of -0.50 and a beta of -0.02.

About Aequus Pharmaceuticals

(Get Free Report)

Aequus Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.

Further Reading

• Five stocks we like better than Aequus Pharmaceuticals